Search results
Results from the WOW.Com Content Network
MuscleTech is a brand of dietary supplements, marketed by Iovate Health Sciences Inc., which includes Hydroxycut. It was owned by Canadian company Kerr Holdings which was acquired by the Xiwang Foodstuffs Company, a Chinese company, for $584 million in 2016.
The heavily marketed diet product line Hydroxycut has been blamed in the death of at least one person and for nearly two dozen serious ailments, prompting the U.S. Food and Drug Administration to ...
I disagree with this edit.The lead needs to summarize relevant aspects of the subject. The single most relevant aspect of Hydroxycut - if we judge by coverage in independent, reliable sources - is the harm caused by the supplement, the questionable behavior of its (previous) manufacturers, and its ultimate withdrawal from the market because of serious safety concerns.
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...
The jury awarded Zachary Young $5 million in compensatory damages and found that the security contractor was also owed punitive damages. The network eventually settled with Young on the punitive ...
The money — which comes from a settlement to a class-action lawsuit that Superior Court Judge Stuart M. Rice has preliminarily approved — is solely for current or former residential customers ...
Hydroxycut is a brand of dietary supplements that is marketed as a weight loss aid. Hydroxycut was originally developed and manufactured by MuscleTech Research and Development; MuscleTech was sold to Iovate Health Sciences in 2003–2004 and declared bankruptcy in 2005; Iovate continues to use MuscleTech as a brand to market Hydroxycut.
The following is a list of the 21 largest civil settlements, reached between the United States Department of Justice and pharmaceutical companies from 2001 to 2017, ordered by the size of the total civil settlement. Some of these matters also resolved criminal fines and penalties, listed in parentheses, but these amounts are not considered when ...